Lallemand Health Solutions has gained new indications for its documented Expert’Biotic IBacilluS+ (a combination of probiotic strain Enterococcus faecium Rosell®-26 and Bacillus…
Infantile stress predisposes individuals to higher anxiety in adulthood. In a new in vivo study, early intake of Lacidofil® (Lallemand Health Solutions…
A new post-hoc analysis confirmed in humans that CEREBIOME® can increase significantly brain-derived neurotrophic factor (BDNF) serum levels as observed several years…
Apsen, located in São Paulo, Brazil, in partnership with Lallemand Health Solutions, are launching in September the first probiotic formulation for the…
Lallemand Health Solutions is pleased to announce its partnership with Prader-Willi syndrome association (PWS) | USA, and “Running for Research,” a charitable initiative to raise funds…
Lallemand Health Solutions will officially launch ROSELLA, its new highly documented licensed strain for Women’s intimate health at Vitafoods Europe Virtual Expo…
Lallemand Health Solutions and Proge Farm® are proud to announce that they have just closed a major licensing deal for the commercialization…
As an expert in yeast fermentation and production since 1923, Lallemand presents a wide range of innovative probiotic yeast solutions. Rediscover S.…
Lallemand Health Solutions launches the brand CEREBIOME® (previously known as Probio’Stick®), a new name for an existing formula combining: Lactobacillus helveticus Rosell®-52…
Lallemand Health Solutions’ three probiotic strains L. helveticus Rosell®-52 (R0052), B. infantis Rosell®-33 (R0033) and B. bifidum Rosell®-71 (R0071), have now completed…
